Florida's Trulieve Reports Solid Quarter Of Rising Revenues

Florida’s Trulieve (CSE: TRUL) (TCNNF) reported that its third-quarter revenue came in at $28.3 million, a 21% sequential increase and 42% increase over last year’s revenue of $19.8 million for the same time period. The net income increased 386% to $17.5 million versus last year’s net income of $3.6 million for the same time period.

“These outstanding results in Q3 demonstrate the meaningful progress we’ve made on our strategic plan since becoming a publicly-traded company in September,” said Kim Rivers, CEO of Trulieve. “Looking ahead, we remain focused on scalable growth, including multi-state operational expansion.”

Following the end of the quarter, Trulieve announced that it was moving beyond the Florida market by making acquisitions of Life Essence, Inc. and Leef Industries, LLC., based in Massachusetts and California respectively.

“Trulieve’s market-leading brand experience continues to result in high patient retention as we deliver consistent, high-quality products, supported by predictive analytics and industry-leading outreach while advocating for patients and physicians,” Rivers continued. “We believe we are well-positioned in continuing to be the dominant leader in the Florida market while firmly establishing our footprint in the Massachusetts and California markets moving forward.”

New Acquisitions

Trulieve is paying approximately $4.1 million for Life Essence, Inc., which includes $3.9
million to be paid over time upon specific locations being approved by the state of Massachusetts. The acquisition will be financed with cash on hand and is expected to close within 60-90 days
when certain regulatory approvals are received.

The company also paid  approximately  $4.0 million for Leef Industries, LLC and this
acquisition will be financed with cash on hand. It is expected to close within 30-60 days
when certain regulatory approvals are received.

The cash and cash equivalents at the end of the quarter were $42.1 million.

Stock Performance

Trulieve stock was lately trading at $12.40 on the OTC Markets. The 52-week low was $7.89 and the year high was $21.

Debra Borchardt

Debra BorchardtDebra Borchardt

Debra Borchardt is the CEO, Co-Founder, and Editor-In-Chief of GMR. She has covered the cannabis industry for several years at Forbes, Seeking Alpha and TheStreet. Prior to becoming a financial journalist, Debra was a Vice President at Bear Stearns where she held a Series 7 and Registered Investment Advisor license. Debra has a Masters degree in Business Journalism from New York University.


3 comments

  • Avatar
    Matt

    November 19, 2018 at 11:20 am

    Knocked it out of the park!

    Reply

  • Avatar
    JON HARRIS

    November 19, 2018 at 2:28 pm

    CAN ANYONE EXPLAIN WHY THE STOCK OF MEDMEN,INC. (MMNFF) is HALTED & NOT TRADING SINCE 1 PM EST FRI. 11/16/18? Thank you.

    Reply

    • Debra Borchardt
      Debra Borchardt

      November 19, 2018 at 3:15 pm

      I’ve emailed the company to ask why and haven’t heard back yet.

      Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

Back to Top

You have Successfully Subscribed!